The Orthofix SpinalStim you’re seeing here was given to me by a friend after their doctor said the therapy could be cut short. This provided a somewhat rare opportunity to observe the device ...

Julie Andrews, the Chief Financial Officer of Orthofix Medical (TASE:PMCN) Inc. (NASDAQ:OFIX), recently sold a portion of her holdings in the company. According to a recent filing, Andrews sold ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, ...

Stifel has upgraded Orthofix Medical (NASDAQ:OFIX) to buy from hold, citing the company's new management, underappreciated earnings power and cash flow generation. The investment bank said it has ...

StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment ...

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period. The most recent guidance for Orthofix ...

Presents Shares and Regional Growth Trends for Cortical, Cancellous, and Hybrid Screws Segmented by Application and End Use PEEK Surgical Screws Market PEEK Surgical Screws Market Dublin, Feb. 07, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...